70 related articles for article (PubMed ID: 35804208)
21. [Nephrotic syndrome as the first manifestation of juvenile systemic scleroderma.].
Couto SB; Sallum AM; Henriques LS; Malheiros DM; Silva CA; Vaisbich MH
Rev Bras Reumatol; 2014 Oct; ():. PubMed ID: 25440709
[TBL] [Abstract][Full Text] [Related]
22. Focal Segmental Glomerulosclerosis and Hyalinosis in a Patient with Spondyloarthritis: A Rare Renal Involvement Case Report.
Boussaid S; Tbini H; Rekik S; Mami I; Ben Fatma L; Jammali S; Bargaoui H; Sahli H; Rais L; Zouaghi MK; Elleuch M
Mediterr J Rheumatol; 2023 Jun; 34(2):257-261. PubMed ID: 37654640
[TBL] [Abstract][Full Text] [Related]
23. The important roles and molecular mechanisms of annexin A
Ye Q; Zhang Y; Zhuang J; Bi Y; Xu H; Shen Q; Liu J; Fu H; Wang J; Feng C; Tang X; Liu F; Gu W; Zhao F; Zhang J; Qin Y; Shang S; Shen H; Chen X; Shen H; Liu A; Xia Y; Lu Z; Shu Q; Mao J
Ann Transl Med; 2021 Sep; 9(18):1452. PubMed ID: 34734004
[TBL] [Abstract][Full Text] [Related]
24. Tubuloglomerular Disease With Cone-Shaped Epiphyses Associated With Hypomorphic Variant and a Novel p.Cys14Arg in the
Bezdíčka M; Zemková D; Skálová S; Hovorková E; Podhola M; Burkert J; Zieg J
Front Pediatr; 2021; 9():752878. PubMed ID: 34805047
[TBL] [Abstract][Full Text] [Related]
25. Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis.
Chhuon C; Herrera-Marcos LV; Zhang SY; Charrière-Bertrand C; Jung V; Lipecka J; Savas B; Nasser N; Pawlak A; Boulmerka H; Audard V; Sahali D; Guerrera IC; Ollero M
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569500
[TBL] [Abstract][Full Text] [Related]
26. Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design.
Daniel-Fischer L; Antlanger M; Cejka D; Eller K; Gauckler P; Odler B; Rudnicki M; Säemann MD; Schmidt A; Sunder-Plassmann G; Wiesholzer M; Windpessl M; Zitt E; Koenig F; Greenbaum LA; Kronbichler A; Aufricht C
Kidney Int Rep; 2024 Feb; 9(2):478-481. PubMed ID: 38344717
[No Abstract] [Full Text] [Related]
27. Combined Rituximab and Daratumumab Treatment in Difficult-to-Treat Nephrotic Syndrome Cases.
Angeletti A; Bin S; Kajana X; Spinelli S; Bigatti C; Caridi G; Candiano G; Lugani F; Verrina EE; La Porta E; Magnasco A; Bruschi M; Cravedi P; Ghiggeri GM
Kidney Int Rep; 2024 Jun; 9(6):1892-1896. PubMed ID: 38899172
[No Abstract] [Full Text] [Related]
28. Enhanced Levels of Glycosphingolipid GM3 Delay the Progression of Diabetic Nephropathy.
Naito S; Nakayama K; Kawashima N
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511118
[TBL] [Abstract][Full Text] [Related]
29. Glycosphingolipid GM3 prevents albuminuria and podocytopathy induced by anti-nephrin antibody.
Kawashima N; Naito S; Hanamatsu H; Nagane M; Takeuchi Y; Furukawa JI; Iwasaki N; Yamashita T; Nakayama KI
Sci Rep; 2022 Sep; 12(1):16058. PubMed ID: 36163359
[TBL] [Abstract][Full Text] [Related]
30. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Cho MH; Hong EH; Lee TH; Ko CW
Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
[TBL] [Abstract][Full Text] [Related]
31. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
Kim JS; Han BG; Choi SO; Cha SK
Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
[TBL] [Abstract][Full Text] [Related]
32. Decreased GM3 correlates with proteinuria in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Naito S; Kawashima N; Ishii D; Fujita T; Iwamura M; Takeuchi Y
Clin Exp Nephrol; 2022 Nov; 26(11):1078-1085. PubMed ID: 35804208
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
[TBL] [Abstract][Full Text] [Related]
34. Glomerular Density and Volume in Renal Biopsy Specimens of Children with Proteinuria Relative to Preterm Birth and Gestational Age.
Koike K; Ikezumi Y; Tsuboi N; Kanzaki G; Haruhara K; Okabayashi Y; Sasaki T; Ogura M; Saitoh A; Yokoo T
Clin J Am Soc Nephrol; 2017 Apr; 12(4):585-590. PubMed ID: 28336816
[TBL] [Abstract][Full Text] [Related]
35. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis.
Deegens JK; Dijkman HB; Borm GF; Steenbergen EJ; van den Berg JG; Weening JJ; Wetzels JF
Kidney Int; 2008 Dec; 74(12):1568-76. PubMed ID: 18813290
[TBL] [Abstract][Full Text] [Related]
36. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]